Literature DB >> 15540491

Which substance abuse treatment facilities offer dual diagnosis programs?

Ramin Mojtabai1.   

Abstract

This report examines the distribution of specialized programs or groups for dual diagnosis clients in substance abuse treatment facilities across the United States and the availability of services often needed by this client population at these facilities. Data from the National Survey of Substance Abuse Treatment Services (N-SSATS) were used to assess the geographic distribution and the characteristics of facilities that offer dual diagnosis treatment programs/groups and to examine the other clinical, social, and health services available in these facilities. Overall, 49.9% of all U.S. substance abuse treatment facilities offered dual diagnosis programs/groups. There were no clear regional variations on availability of these services. There were, however, clear variations based on facility ownership and treatment modality. Facilities owned by the federal, state, and local governments, and those offering inpatient treatment were more likely than were other facilities to offer dual diagnosis programs/groups. A large proportion of facilities with specialized dual diagnosis programs/ groups did not offer mental, social, or health services often needed by dual diagnosis clients. It is concluded that specialized programs for dual diagnosis clients are offered in many different substance abuse treatment facilities, attesting to the growing recognition of the special needs of this group of clients. However, dissemination of comprehensive services often needed to meet the special needs of these clients has not kept pace with the spread of specialized programs, highlighting the need for establishing and implementing standard evidence-based guidelines for dual diagnosis treatment programs in these settings.

Mesh:

Year:  2004        PMID: 15540491     DOI: 10.1081/ada-200032281

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  13 in total

1.  Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders.

Authors:  Ramin Mojtabai; Lian-Yu Chen; Christopher N Kaufmann; Rosa M Crum
Journal:  J Subst Abuse Treat       Date:  2013-08-29

2.  Organizational characteristics of drug abuse treatment programs for offenders.

Authors:  Christine E Grella; Lisa Greenwell; Michael Prendergast; David Farabee; Elizabeth Hall; Jerome Cartier; William Burdon
Journal:  J Subst Abuse Treat       Date:  2007-03-09

3.  Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders.

Authors:  Christine E Grella; Judith A Stein
Journal:  Psychiatr Serv       Date:  2006-07       Impact factor: 3.084

4.  Childhood sexual abuse characteristics, intimate partner violence exposure, and psychological distress among women in methadone treatment.

Authors:  Malitta Engstrom; Nabila El-Bassel; Louisa Gilbert
Journal:  J Subst Abuse Treat       Date:  2012-03-22

5.  Use of health care services by patients with co-occurring severe mental illness and substance use disorders.

Authors:  Marius N Kêdoté; Astrid Brousselle; François Champagne
Journal:  Ment Health Subst Use       Date:  2008-09-19

6.  The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Brendan Saloner; Rosa M Crum; Marc Kealhofer; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

7.  Age and HIV sexual risk among women in methadone treatment.

Authors:  Malitta Engstrom; Tazuko Shibusawa; Nabila El-Bassel; Louisa Gilbert
Journal:  AIDS Behav       Date:  2011-01

8.  Unmet need for mental health care in schizophrenia: an overview of literature and new data from a first-admission study.

Authors:  Ramin Mojtabai; Laura Fochtmann; Su-Wei Chang; Roman Kotov; Thomas J Craig; Evelyn Bromet
Journal:  Schizophr Bull       Date:  2009-06-08       Impact factor: 9.306

9.  Developing an integrated treatment for substance use and depression using cognitive-behavioral therapy.

Authors:  Karen Chan Osilla; Kimberly A Hepner; Ricardo F Muñoz; Stephanie Woo; Katherine Watkins
Journal:  J Subst Abuse Treat       Date:  2009-06-21

10.  Dual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems.

Authors:  Mark P McGovern; Chantal Lambert-Harris; Heather J Gotham; Ronald E Claus; Haiyi Xie
Journal:  Adm Policy Ment Health       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.